Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (161-170 of 395) with videos related to

Pageof 40
Sort By:
Nature Aging|April 28, 2023
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathologyJoana B Pereira, Shorena Janelidze, Olof Strandberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 17, 2012
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosisKristin Augutis, Markus Axelsson, Erik Portelius, et al.
Pain|May 9, 2020
Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotypeMartin Flores Bjurström, Mikael Bodelsson, Agneta Montgomery, et al.
Research Square|November 21, 2023
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptomsIda Arvidsson, Olof Strandberg, Sebastian Palmqvist, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Susan Landau, et al.
Alzheimer'S Research & Therapy|January 6, 2025
Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studiesEftychia Bellou, Woori Kim, Ganna Leonenko, et al.
Brain Communications|November 28, 2024
Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disordersBárbara Fernandes Gomes, Atul Kumar, Nicholas J Ashton, et al.
Neurology|May 3, 2023
Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic ChangesClaudia Cicognola, Niklas Mattsson-Carlgren, Danielle van Westen, et al.
Brain : a Journal of Neurology|November 3, 2025
Estimating the time course of biomarker changes in Alzheimer's diseaseLars Lau Raket, Alexa Pichet Binette, Niklas Mattsson-Carlgren, et al.
Scientific Reports|November 8, 2016
Serum neurofilament light protein predicts clinical outcome in traumatic brain injuryPashtun Shahim, Magnus Gren, Victor Liman, et al.
Pageof 40

Showing results (161-170 of 395) with videos related to

Sort By:
Pageof 40
Nature Aging|April 28, 2023
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathologyJoana B Pereira, Shorena Janelidze, Olof Strandberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 17, 2012
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosisKristin Augutis, Markus Axelsson, Erik Portelius, et al.
Pain|May 9, 2020
Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotypeMartin Flores Bjurström, Mikael Bodelsson, Agneta Montgomery, et al.
Research Square|November 21, 2023
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptomsIda Arvidsson, Olof Strandberg, Sebastian Palmqvist, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Susan Landau, et al.
Alzheimer'S Research & Therapy|January 6, 2025
Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studiesEftychia Bellou, Woori Kim, Ganna Leonenko, et al.
Brain Communications|November 28, 2024
Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disordersBárbara Fernandes Gomes, Atul Kumar, Nicholas J Ashton, et al.
Neurology|May 3, 2023
Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic ChangesClaudia Cicognola, Niklas Mattsson-Carlgren, Danielle van Westen, et al.
Brain : a Journal of Neurology|November 3, 2025
Estimating the time course of biomarker changes in Alzheimer's diseaseLars Lau Raket, Alexa Pichet Binette, Niklas Mattsson-Carlgren, et al.
Scientific Reports|November 8, 2016
Serum neurofilament light protein predicts clinical outcome in traumatic brain injuryPashtun Shahim, Magnus Gren, Victor Liman, et al.
Pageof 40